Navigation Links
3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
Date:11/24/2008

SHENYANG, China, Nov. 24 /PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that Dr. Yingfei Wei, Chief Scientific Officer, will present at the Piper Jaffray 20th Annual Health Care Conference in New York on Tuesday, December 2, 2008 at 11:00AM (Eastern Time).

The presentation will be webcast live (audio only) and can be accessed on the Conference Appearances section of the Investors page of the 3SBio website at: http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of the presentation and accompanying slides will be available on the 3SBio website until January 1, 2008.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

For more information, please visit 3SBio on the web at: http://www.3sbio.com .

    For further information, please contact:

    Investor Contact:
     David Chen, COO
     3SBio Inc.
     Email: ir@3sbio.com

    Investor Relations (US):
     Mahmoud Siddig
     Taylor Rafferty
     Tel: +1-212-889-4350

    Investor Relations (HK):
     Ruby Yim
     Taylor Rafferty
     Tel: +852-3196-3712

    Media Contact:
     Jason Marshall
     Taylor Rafferty
     Tel: +1-212-889-4350

'/>"/>
SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. 3SBio Inc. Announces Third Quarter 2008 Results
2. 3SBio Inc. Files for SFDA Approval of NuLeusin
3. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
4. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
5. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
6. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
7. 3SBio Inc. Announces Results of Annual General Meeting
8. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. 3SBio Inc. to Hold Annual General Meeting
10. 3SBio Inc. Announces Second Quarter 2008 Results
11. 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology:
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):